| HOME >> BIOLOGY >> TECHNOLOGY |
REDWOOD CITY, Calif., Aug. 17 /PRNewswire/ -- Ingenuity® Systems, the leading provider of information solutions for life science researchers, today announced the release of the white paper, "Best Practices for Assessing Toxicity throughout the Drug Discovery Process: Toxicogenomics." The white paper is based on input from industry experts and shows how multidisciplinary toxicology teams in drug discovery can leverage toxicogenomics and IPA® for improved predictive toxicology and mechanistic toxicity analysis.
Understanding the basic biological mechanisms related to toxicity is a top priority for both traditional toxicologists and other researchers whose understanding of toxicity can inform decision making at all phases of a research project. By complementing a traditional toxicological approach with toxicogenomics, researchers get a better interpretation of large, complex amounts of data with lots of variables, can detect toxicity earlier in drug discovery for faster project decisions, and – most significantly – can better understand molecular level events that underlie toxicity.
Dr. Phil Hewitt, Head of Toxicogenomics at Merck-Serono, believes that gene expression profiling has the greatest potential for improving mechanistic insight and therefore adds a high value to Tox and Safety studies. According to Dr. Hewitt, "Implementing toxicogenomics with traditional tox approaches will help researchers detect toxicity earlier. Assessing toxicity is not always clear, and incorporating another source of information can only complement traditional animal studies."
IPA-Tox®, a capability within IPA, is the industry leading toxicogenomics software solution for analyzing this type of expression data to obtain actionable insights. With IPA-Tox, scientists can analyze large scale datasets (genomic and proteomic datasets, dose response datasets, etc.) in order to identify the key functions and pat
'/>"/>
| SOURCE Ingenuity Systems Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. Ingenuity Systems Announces New Distributor for Greece, Turkey and the Balkans
2. Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website
3. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
4. Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity
5. Delcath Systems Announces the Sale of 5,185,000 Shares of Common Stock
6. Axela Acquires Xceed Molecular Creating Powerhouse in Robust and Easy-to-Use Systems for Translational Medicine
7. FRC Systems International State-of-the-art Industrial Wastewater Treatment Systems
8. Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010
9. Dehaier Medical Systems Signs $1.6 Million Oxygen-Chip Sales Contract
10. delSECUR CORPORATION Announces Organizational Update as QTECH SYSTEMS INC. Expands Leadership Team
11. Melissa Kemp, Ph.D., Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc.
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |